News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,028 Results
Type
Article (14248)
Company Profile (281)
Press Release (253499)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79529)
Career Advice (153)
Deals (13229)
Drug Delivery (35)
Drug Development (50462)
Employer Resources (31)
FDA (5722)
Job Trends (5134)
News (144432)
Policy (10032)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21672)
ALS (64)
Alzheimer's disease (847)
Antibody-drug conjugate (ADC) (100)
Approvals (5751)
Artificial intelligence (123)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1476)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (116)
Cell therapy (328)
Cervical cancer (8)
Clinical research (41077)
Collaboration (542)
Compensation (258)
Complete response letters (13)
COVID-19 (1034)
CRISPR (41)
C-suite (163)
Cystic fibrosis (76)
Data (1516)
Denatured (11)
Depression (29)
Diabetes (137)
Diagnostics (1299)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29816)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48583)
Executive appointments (459)
FDA (6419)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (96)
Generative AI (10)
Gene therapy (252)
GLP-1 (365)
Government (1079)
Grass and pollen (2)
Guidances (21)
Healthcare (6594)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (91)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7274)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (208)
Leadership (3)
Legal (1386)
Liver cancer (33)
Lung cancer (205)
Lymphoma (100)
Machine learning (3)
Management (7)
Manufacturing (138)
MASH (53)
Medical device (2599)
Medtech (2600)
Mergers & acquisitions (6286)
Metabolic disorders (388)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1255)
NextGen: Class of 2025 (2017)
Non-profit (852)
Northern California (1699)
Now hiring (22)
Obesity (193)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (128)
Patient recruitment (76)
Peanut (35)
People (25641)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14509)
Phase II (19106)
Phase III (12079)
Pipeline (804)
Policy (44)
Postmarket research (852)
Preclinical (6136)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1419)
Recruiting (12)
Regulatory (8638)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1485)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1974)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (8)
The Weekly (36)
United States (13212)
Vaccines (213)
Venture capitalists (32)
Weight loss (109)
Women's health (15)
Worklife (2)
Date
Today (123)
Last 7 days (505)
Last 30 days (1578)
Last 365 days (19592)
2025 (6207)
2024 (20551)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17312)
Australia (2935)
California (3846)
Canada (1140)
China (358)
Colorado (149)
Connecticut (151)
Delaware (102)
Europe (37235)
Florida (463)
Georgia (115)
Idaho (16)
Illinois (231)
India (10)
Indiana (91)
Iowa (2)
Japan (74)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (472)
Massachusetts (3068)
Michigan (70)
Minnesota (144)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (961)
New Mexico (12)
New York (1040)
North Carolina (551)
North Dakota (5)
Northern California (1699)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (737)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1485)
Tennessee (25)
Texas (446)
Utah (53)
Virginia (78)
Washington D.C. (30)
Washington State (351)
Wisconsin (15)
268,028 Results for "janux therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
February 27, 2025
·
8 min read
Press Releases
Janux Therapeutics Announces Proposed Public Offering
December 3, 2024
·
4 min read
Press Releases
Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer
January 24, 2025
·
5 min read
Business
Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux) today reported financial results for the first quarter ended March 31, 2024 and provided a business update.
May 7, 2024
·
7 min read
Press Releases
Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
November 7, 2024
·
7 min read
Business
Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux) today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.
March 8, 2024
·
9 min read
Press Releases
Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
December 5, 2024
·
5 min read
Biotech Beach
Janux’s Stock Skyrockets 172% on Positive Results for Two Candidates in Phase I Trials
Janux Therapeutics on Monday announced positive updated clinical data for both of its clinical programs in prostate cancer advanced or metastatic solid tumors.
February 27, 2024
·
2 min read
·
Tyler Patchen
Biotech Beach
Janux Therapeutics Announces Proposed Public Offering of Common Stock
Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager and Tumor Activated Immunomodulator platforms, announced that it has commenced an underwritten public offering of $175.0 million of shares of its common stock.
February 27, 2024
·
4 min read
Business
Janux Therapeutics Promotes Co-Founder Tommy DiRaimondo, Ph.D. to Chief Scientific Officer
Janux Therapeutics, Inc. today announced the promotion of Dr. Tommy DiRaimondo to Chief Scientific Officer.
January 8, 2024
·
5 min read
1 of 26,803
Next
